Back to List View Graph View

CTNNA1

CTNNA1 encodes catenin alpha 1 (α-catenin), a protein associated with catenin signaling.

Where the papers sit

9 papers from the last 6 months study CTNNA1 directly · updated from PubMed 14 Nov 2026

Study type 0 clinical trials · 1 observational · 2 human data · 6 preclinical

Themes one subject · 1 new direction

Those 9 are all about one subject.

  • Catenin Biology

    Catenin-centered work links alpha-catenin and β-catenin to epithelial integrity, Wnt signaling, cancer, inflammation and tissue remodeling. Proteomic and proximity-mapping studies are expanding the known interaction and ubiquitination networks. Pharmacological approaches target Wnt/β-catenin activity or use it to improve radiotherapy, immunotherapy and anti-inflammatory treatment. The field remains mechanistically broad, with no single therapeutic direction established.

    9 papers

NEW DIRECTION

Germline CTNNA1 is presented as a susceptibility factor for a distinctive spectrum of synchronous thyroid lesions

The case of synchronous minimally invasive follicular thyroid carcinoma, papillary thyroid carcinoma, and diffuse adenomatoid nodules in a woman with a pathogenic germline CTNNA1 mutation 42823177Oct assigns CTNNA1 an inherited disease-susceptibility role rather than the β-catenin pathway, therapeutic-target, or tissue-remodeling roles described elsewhere in the set. It expands CTNNA1-associated disease to a distinctive combination of thyroid neoplasia and proliferative lesions, while the absence of a PTEN alteration supports the mutation as the notable genetic finding in this case.

Papers

The 9 papers from the last 6 months that study CTNNA1 directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Catenin Biology (9)
  1. Integrated Proteomic and Ubiquitinomic Reveal Ubiquitination Remodeling in Pelvic Organ Prolapse. Journal of proteome research · 6 Nov 2026 PMID 42992879
  2. Alpha-catenin Mutation-associated Synchronous Follicular Thyroid Carcinoma and Papillary Thyroid Carcinoma With Numerous Adenomatoid Nodules. Anticancer research · 1 Oct 2026 PMID 42823177
  3. Quercetin ameliorates rheumatoid arthritis-associated bone erosion via inhibiting the Wnt3a/β-catenin signaling axis. Molecular biology reports · 15 Sept 2026 PMID 42742793
  4. Harnessing (-)-epigallocatechin-3-gallate (EGCG) with chitosan-coated liposomes to modulate the radiation effect in cancer cells through alteration in the miR-139-5p-β-catenin axis. Biomaterials science · 15 Sept 2026 PMID 42741861
  5. Comprehensive proximity proteomics expand the known interactome of the oncoprotein β-catenin. Scientific reports · 2 Sept 2026 PMID 42680804
  6. All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma. Signal transduction and targeted therapy · 25 Aug 2026 PMID 42642387
  7. Design and development of 2,7-disubstituted 6-methoxyquinazolin-4 (3H)-ones as potential anti-cancer agents possibly through downregulation of Wnt/β-catenin/TCF4 signaling pathway. Future medicinal chemistry · 17 Aug 2026 PMID 42605575
  8. Targeting the METTL14/Wnt9a/β-catenin pathway with pharmacological inhibitors enhances radiotherapy and immunotherapy efficacy in non-small cell lung cancer. European journal of pharmacology · 6 Aug 2026 PMID 42562044
  9. Overexpression of CD97 in intestinal epithelial cells attenuates LPS-induced pro-inflammatory cytokine induction via stabilization of β-catenin early in life. PloS one · 30 Jul 2026 PMID 42531273

By study type

Observational studies and case reports (1)
  1. Alpha-catenin Mutation-associated Synchronous Follicular Thyroid Carcinoma and Papillary Thyroid Carcinoma With Numerous Adenomatoid Nodules. Anticancer research · 1 Oct 2026 PMID 42823177
Human data, design not indexed (2)
  1. Integrated Proteomic and Ubiquitinomic Reveal Ubiquitination Remodeling in Pelvic Organ Prolapse. Journal of proteome research · 6 Nov 2026 PMID 42992879
  2. Comprehensive proximity proteomics expand the known interactome of the oncoprotein β-catenin. Scientific reports · 2 Sept 2026 PMID 42680804
Preclinical: animal, cell and lab studies (6)
  1. Quercetin ameliorates rheumatoid arthritis-associated bone erosion via inhibiting the Wnt3a/β-catenin signaling axis. Molecular biology reports · 15 Sept 2026 PMID 42742793
  2. Harnessing (-)-epigallocatechin-3-gallate (EGCG) with chitosan-coated liposomes to modulate the radiation effect in cancer cells through alteration in the miR-139-5p-β-catenin axis. Biomaterials science · 15 Sept 2026 PMID 42741861
  3. All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma. Signal transduction and targeted therapy · 25 Aug 2026 PMID 42642387
  4. Design and development of 2,7-disubstituted 6-methoxyquinazolin-4 (3H)-ones as potential anti-cancer agents possibly through downregulation of Wnt/β-catenin/TCF4 signaling pathway. Future medicinal chemistry · 17 Aug 2026 PMID 42605575
  5. Targeting the METTL14/Wnt9a/β-catenin pathway with pharmacological inhibitors enhances radiotherapy and immunotherapy efficacy in non-small cell lung cancer. European journal of pharmacology · 6 Aug 2026 PMID 42562044
  6. Overexpression of CD97 in intestinal epithelial cells attenuates LPS-induced pro-inflammatory cytokine induction via stabilization of β-catenin early in life. PloS one · 30 Jul 2026 PMID 42531273